Previously at MeiraGTx, GSK and Novartis, Dr. Leighton will help Chemify scale the company’s operational capacity to meet ...
Business Wire
|
January 10, 2025
Leveraging Real Chemistry’s differentiated deep biopharma expertise and Corval’s cutting-edge commercialization planning platform, the collaboration aims to accelerate ...
October 2, 2024
Scientist.com hosts webinar series exploring the fundamentals of neural networks and the latest applications of large language models ...
July 30, 2024
Three new AI-powered products connect strategic priorities to the optimal tactic mix and resource allocation to drive higher ...
September 26, 2023
Tübingen, Germany-based CureVac, a biopharmaceutical company developing transformative medicines based on mRNA, announced on Tuesday, February 7, the ...
Editorial team
February 9, 2023
TargED Biopharmaceuticals, an Utrecht-based biotechnology company focused on developing improved treatments for thrombotic diseases, announced that it has ...
February 24, 2022
Angelini Pharma - part of the private Italian Angelini Group - has announced that it is looking to acquire Arvelle Therapeutics, a Swiss-based biopharmaceutical company
January 5, 2021
SOPHIA ANTIPOLIS, France–(BUSINESS WIRE)–Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, “Median” or the “Company”), manufacturer of ...
July 11, 2025
DUBLIN–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been honoured in the ...
July 7, 2025
Class IIb CE marking is a prerequisite for Median’s eyonis® LCS Software as a Medical Device marketing in ...
July 1, 2025
The European Innovation Council (EIC) has selected 40 companies (startups and SMEs) to receive funding following its latest ...
Vigneshwar Ravichandran
June 30, 2025
New European hub set to transform negotiation training, sales force performance, and market access with advanced AI ZUG, ...
June 17, 2025
01
02
03
04
05
More
[wp_dark_mode style="2"]
01
From telecom veteran to Dutch Startup Visa success: The Jignesh Dave story